This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD, hospital admissions 3, with pneumonia sepsis
ILD_HOSPITAL_PNEUMONIA_SEPSIS
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions
PULM_PNEUMONIA_SEPSIS
59919
Check pre-conditions, main-only, mode, registry filters None
0 out of 7 registries used, show all original rules.
0
Check minimum number of events None
0
Remove individuals based on genotype QC
2180
ILD_HOSPITAL_PNEUMONIA_SEPSIS
Control definitions
Control conditions
not PULM_PNEUMONIA_SEPSIS
Extra metadata
First used in FinnGen datafreeze
DF2
No data for upset plot.
No data for upset table.
Similar endpoints
↥List of similar endpoints to
ILD, hospital admissions 3, with pneumonia sepsis
based on the number of shared cases.
Broader endpoints:
- ILD, hospital admission 2, with pulmonary infections
- ILD, hospital admissions
- Interstitial lung disease
- Other interstitial pulmonary diseases
- Interstitial lung disease endpoints
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2180 | 854 | 1326 |
| Unadjusted prevalence (%) | 0.58 | 0.41 | 0.80 |
| Mean age at first event (years) | 67.04 | 64.34 | 68.78 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ILD_HOSPITAL_PNEUMONIA_SEPSIS – ILD, hospital admissions 3, with pneumonia sepsis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after ILD, hospital admissions 3, with pneumonia sepsis
↥Endpoint not on priority list, no data to show.